Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature review

Fig. 2

Clinical and microbiological courses of SFTS and invasive fungal infections. The level of SFTSV-RNA peaked on day 5 of admission and became undetectable (below the detection limit) on day 16. As the level of SFTSV-RNA decreased, platelet counts recovered without platelet transfusion (arrows). Sputum SFTSV-RNA was positive until day 71 even after serum SFTSV-RNA became undetectable. Sputum SFTSV-RNA became undetectable on day 128. SFTSV, severe fever with thrombocytopenia syndrome virus; rTM, recombinant human thrombomodulin; IVIG, intravenous immunoglobulin; MINO, minocycline; LVFX, levofloxacin; MEPM, meropenem; TAZ/PIPC, tazobactam/piperacillin; VCM, vancomycin; CPFG, caspofungin; VRCZ voriconazole; L-AMB, liposomal amphotericin B; BALF, bronchoalveolar lavage fluid; CSF, cerebrospinal fluid

Back to article page